期刊文献+

骨痹消对大鼠佐剂性关节炎血清中TNF-α、IL-1β、IL-6水平的影响 被引量:2

Effect of Gu Bi Xiao on TNF-а,IL-1β,IL-6 in Rats with AIA
下载PDF
导出
摘要 目的:观察骨痹消对关节损伤的防治作用及机制,为AS的治疗提供实验依据。方法:取Wistar雄性大鼠40只,随机分为4组,每组10只。分别为模型组、中药组、罗非西布组、对照组。用佛氏佐剂注射于模型组、中药组、罗非西布组大鼠左后足掌皮下,造佐剂性关节炎模型;对照组注射等量生理盐水。中药组和罗非西布组分别灌胃给中药水煎剂2ml/200g、罗非昔布2ml/200g(0.2mg),模型组和对照组灌胃给自来水2ml/200g,每天灌胃1次。结果:在使用中药骨痹消方后,大鼠血清TNF-α、IL-1β、IL-6水平均显著下降。结论:中药骨痹消对大鼠佐剂性关节炎有一定的治疗作用,可减轻炎症反应和关节肿胀,改善关节功能,其机制可能与下调TNF-α、IL-1β、IL-6,抑制炎症反应有关。 Objective:To explore preventive and treatment effects of Gu Bi Xiao on joint injuries and its mechanism, providing lab data for Ankylosing Spondylitis treatment. Methods:Forty Wister male rats were randomly divided into 4 groups (n = 10) : the model group, Chinese medicine group, Rofecoxib group, the three of which established AIA model by injecting Freud's Adjuvant into the plantar surface of left hind paw, and control group injected with same volume of Sodium Chloride. Chinese medicine decoction (2mL/200g) and Rofecoxib (2mL/200g), or tap water (2mL/200g) were administered respectively to four groups by gavages daily. Results :TNF-a, IL-1β, IL-6 in Rats with AIA decreased markedly after dministration of Gu Bi Xiao. Conelusion:Gu Bi Xiao is effective in the treatment of AIA by relieving inflammation and joint swelling and improving joint functions, which may have something to do with down-regulation of TNF-a, IL-1β, IL-6.
出处 《世界中医药》 CAS 2008年第5期312-313,共2页 World Chinese Medicine
关键词 强直性脊柱炎 中医药疗法 骨痹消 临床分析 Ankylosing Spondylitis Chinese Medical Therapy @ Gu Bi Xiao
  • 相关文献

参考文献4

二级参考文献25

  • 1林红,贺永怀,黎燕,陆应麟,沈倍奋.Ⅱ型胶原蛋白与弗氏完全佐剂大鼠关节炎模型的建立和比较[J].中国实验动物学报,1999,7(1):1-6. 被引量:54
  • 2关根知世子.巨噬细胞系的辅助分子[J].临床免疫(日),1996,28:68-74.
  • 3Haussiau FA, Devogelaer JP, Van Damme J, et al. lnterleukin -6 in synovial fluid and serum of patients with rheumafoid arthritis and other rinflammatory arthritis[J]. Arthritis Rheum, 1988,31:784 -788.
  • 4Vander Linden SM, Valkenburg HA, Cats A. A Evaluation of diagnostic criteria for ankylosing spondy ltis : a proposal for modification of yew york criteria[ J]. Arthritis Rheum, 1984,27 : 361 - 364.
  • 5Jon DL, Eric C, Randolph JN. Function of CD40 and ligand, gp39(CD40L) [J]. Critical Reviews in Immunology, 1996, 16:59 -108.
  • 6Gratacos J, Collodo A, Filella X, et al. Serum cytokines ( IL-6,TNF, IL-1, IFN-γ) in ankylosing spoudylitis[J]. Br J Rheumatol,1994,33:927 -931.
  • 7Archen J, Keat A. Ankylosing spondylitis: time to focus on ankylosis[J]. J Rheumatol, 1999,26:761-764.
  • 8林昌松 刘丽娟 李小兵.活动期强直性脊柱炎患者IL—6、TNF—α水平的观察[J].中华现代中西医杂志,2004,2(11):987-987.
  • 9Feldmann M, Brennan FM, Foxwell BM, et al. The role of TNF-αlpha and IL-1 in rheumatoid arthritis[J]. Curr Dir Autoimmun,2001,3:188-199.
  • 10Issekutz A C, Meager A, Otterness I, et al. The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis [J]. Clin Exp Immunol, 1994,97(1):26-33.

共引文献20

同被引文献34

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部